Discover New Solubility Enhancement Technologies at the 14th Global DDF Summit in Berlin

Are you working with a poorly water-soluble API? Join Lubrizol Life Science (LLS Health) at the Global DDF Summit from May 31st to June 2nd as we showcase our solubility-enhancing excipients and CDMO services for BCS Class II and IV APIs:

• Oral-Grade Apinovex™ Polymers: high, stable drug loading for amorphous solid dispersions.
• Injectable-Grade Apisolex™ Polymers: increase solubility of hydrophobic APIs up to 50,000x.
• Nanomilling Services: improve dissolution rate with a trusted development and GMP manufacturing partner.

Featured Presentation

Apisolex™ and Apinovex™ Polymers: Efficient New Tools for Solubility Enhancement and Lifecycle Management

Date: May 31st, 2023
Time (CET): 10h – 10:30h Local Time
Description: Don’t miss our presentation on Lubrizol’s novel solubility-enhancing excipients: Apinovex™ Polymers for oral amorphous solid dispersions and Apisolex™ Polymers for injectable formulations.

Nick DiFranco will explain how these polymers enable:

• Efficient parenteral and oral delivery of low-solubility compounds
• New case study and in vivo safety/toxicity data for 2023
• Development of patent-protected formulations for new chemical entities (NCEs) and differentiated 505(b)(2) products
• Simple, scalable manufacturing processes using readily available equipment
• High drug loading and stability benefits versus other excipients, demonstrated by experimental data with model APIs

We look forward to seeing you at the 2023 Global DDF Summit!